The NHS saves over £300 million in a year by switching to better value medicines

NHS Improvement | July 2018 | The NHS saves £324 million in a year by switching to better value medicines

NHS Improvement have released figures that show how the NHS has made savings of £324 million using biosimilar medicines, a biological medicine highly similar to another biological medicine.  These better value biosimilar and generic medicines, which are just as safe and effective as the more expensive original biological versions,  an example being the Biosimilars of trastuzumab, breast cancer drug prescribed in place of the branded medicine Herceptin. They are also being used to treat conditions including rheumatoid arthritis, some forms of cancer and inflammatory bowel conditions.

pill-1884777_1920Further details of savings can be found at NHS Improvement 

Related:

The King’s Fund From lab to bedside: ensuring new medicines are available in a cost-effective and timely way

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s